CENP-A Ubiquitylation Is Indispensable to Cell Viability.

CENP-A centromere centromere identity conditional knockout system epigenetics kinetochore mitosis monoubiquitin posttranslational modifications (PTMs) ubiquitylation

Journal

Developmental cell
ISSN: 1878-1551
Titre abrégé: Dev Cell
Pays: United States
ID NLM: 101120028

Informations de publication

Date de publication:
23 09 2019
Historique:
received: 24 09 2018
revised: 30 04 2019
accepted: 14 07 2019
entrez: 25 9 2019
pubmed: 25 9 2019
medline: 19 5 2020
Statut: ppublish

Résumé

CENP-A is a centromere-specific histone H3 variant that epigenetically determines centromere identity, but how CENP-A is deposited at the centromere remains obscure. We previously reported that CENP-A K124 ubiquitylation, mediated by the CUL4A-RBX1-COPS8 complex, is essential for CENP-A deposition at the centromere. However, a recent report stated that CENP-A K124R mutants show no defects in centromere localization and cell viability. In the present study, we found that EYFP tagging induces additional ubiquitylation of EYFP-CENP-A K124R, which allows the mutant protein to bind to HJURP. Using a previously developed conditional CENP-A knockout system and our CENP-A K124R knockin mutant created by the CRISPR-Cas9 system, we show that the Flag-tagged or untagged CENP-A K124R mutant is lethal. This lethality is rescued by monoubiquitin fusion, indicating that CENP-A ubiquitylation is essential for viability.

Identifiants

pubmed: 31550462
pii: S1534-5807(19)30621-5
doi: 10.1016/j.devcel.2019.07.015
pmc: PMC6761987
mid: NIHMS1535109
pii:
doi:

Substances chimiques

Centromere Protein A 0
Mutant Proteins 0
Peptides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

683-689.e6

Subventions

Organisme : NCI NIH HHS
ID : R21 CA205659
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Oncogene. 2006 Jul 13;25(30):4133-46
pubmed: 16501598
J Virol Methods. 2006 Dec;138(1-2):85-98
pubmed: 16950522
J Cell Biol. 2007 Mar 12;176(6):795-805
pubmed: 17339380
J Cell Biol. 2007 Jul 16;178(2):283-96
pubmed: 17620410
Cell. 2009 May 1;137(3):472-84
pubmed: 19410544
Cell. 2009 May 1;137(3):485-97
pubmed: 19410545
Cell Death Differ. 2010 Jun;17(6):1011-24
pubmed: 20057499
Mol Cell Proteomics. 2012 May;11(5):138-47
pubmed: 22474085
Dev Cell. 2014 Sep 8;30(5):496-508
pubmed: 25203206
Dev Cell. 2015 Mar 9;32(5):589-603
pubmed: 25727006
J Vis Exp. 2016 Mar 03;(109):e53732
pubmed: 26967065
Cell Rep. 2016 Apr 5;15(1):61-76
pubmed: 27052173
Dev Cell. 2017 Jan 9;40(1):104-113
pubmed: 28073008
Epigenetics Chromatin. 2017 Apr 4;10:17
pubmed: 28396698
Cell Cycle. 2017 Sep 17;16(18):1683-1694
pubmed: 28816574
Chromosoma. 2018 Sep;127(3):279-290
pubmed: 29569072
Trends Biochem Sci. 1995 Jul;20(7):257-9
pubmed: 7667876

Auteurs

Yohei Niikura (Y)

Greehey Children's Cancer Research Institute, Department of Molecular Medicine, UT Health Science Center San Antonio, 8403 Floyd Curl Drive, San Antonio, TX 78229-3000, USA; MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Nanjing, Jiangsu Province 210061, China. Electronic address: niikura@nicemice.cn.

Risa Kitagawa (R)

Greehey Children's Cancer Research Institute, Department of Molecular Medicine, UT Health Science Center San Antonio, 8403 Floyd Curl Drive, San Antonio, TX 78229-3000, USA.

Lei Fang (L)

Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu Province 210093, China.

Katsumi Kitagawa (K)

Greehey Children's Cancer Research Institute, Department of Molecular Medicine, UT Health Science Center San Antonio, 8403 Floyd Curl Drive, San Antonio, TX 78229-3000, USA. Electronic address: kitagawak@uthscsa.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH